TherapyEdge (ABL group) and TCELS To Cooperate for the National HIV/AIDS Surveillance...

TherapyEdge (ABL group) and TCELS To Cooperate for the National HIV/AIDS Surveillance Program in Thailand Using The TherapyEdge-ViroScore System

LUXEMBOURG--(Business Wire)--
The multi-centre and prospective surveillance program of HIV drug
resistance emergence and transmission in Thailand starts in 2008

The Thailand Centre of Excellence for Life Sciences (TCELS,
Bangkok (Thailand)), TherapyEdge Inc. (TE; Boston (MA)) and Advanced
Biological Laboratories (ABL), S.A (Luxembourg), today announced the
completion of a partnership agreement to set up a national,
multi-centric, prospective HIV/AIDS surveillance program in Thailand
for the 3 forthcoming years.

Under the terms of the agreement, ABL-TE will equip the fifteen
major hospitals and reference laboratories in Thailand with the Thai
Edition of the TherapyEdge-ViroScore platform. TCELS and ABL-TE will
jointly fund the surveillance system for the program. Cybeles Life
Science (Germany) did lead the communication of the project between
the parties and the local subsidiary will provide technical support.
The Pharmacogenomics Group of TCELS, directed by Prof. Wasun
Chantratita will conduct the daily operations and will handle the
studies of data collected through this network of excellence. All the
partners will exploit associated know-how.

"The TherapyEdge and ViroScore Suite systems, Thai Edition, will
be the main software platform for HIV/AIDS surveillance in Thailand
which now allows us to have an electronic patient database. It will be
the key for developing more efficient and safer therapies. This will
also reduce the time and procedures to discover and develop new drugs
resulting in lower overall costs and expenses in medications for the
public health system", said Dr Tongchai Thavichachart, CEO of TCELS.

"After we have tested TherapyEdge-ViroScore extensively for 2
years with adaptations to suit our local demand, it turns out to be an
excellent decision support system for HIV/AIDS disease management at
the national level for resource-limited countries like Thailand. In
2008-2010, TherapyEdge-ViroScore will be served to 15 HIV/AIDS
hospitals nationwide with the support from TCELS and Thai Ministry of
Public Health --U.S. CDC Collaboration (TUC). We expect to see
significant improvements of HIV/AIDS treatment in hospitals equipped
with the TherapyEdge-ViroScore Suite system when compared to the
hospitals using only HIV/AIDS standard treatment guidelines. We are
confident that this advanced platform could be practically applied to
improve the health of HIV-1 infected Thai patients and would reduce in
general medical expenditures in developing countries such as
Thailand," said Pr Wasun Chantratita.

"This partnership with TCELS and Thai scientific experts provides
the ABL group with a novel experience for the deployment of its unique
technology. The Thai government and local experts have shown in the
past significant successes to apply treatment programs, and continue
creating innovative partnerships to assess the efficiency of their
current and future HIV/AIDS programs," said Dr Chalom B. Sayada, CEO
of ABL-TE.

About TherapyEdge, Inc. and ABL, S.A.

TherapyEdge and ABL's expertise lies within infectious diseases,
with particular focus on resistance patterns and clinical outcome
predictors for HIV-1, tuberculosis, hepatitis, malaria and human
papillomavirus (HPV) infections. http://www.therapyedge.com

About TCELS

The Thailand Centre of Excellence for Life Sciences (TCELS) was
established by the Royal Decree endorsed on June 18, 2004 and serves
as an independent public organization under supervision of the Royal
Thai Government. TCELS is focusing on investment and development of
life sciences business through partnership with foreign investors, as
well as promoting life sciences research and developments, with the
goal to make Thailand become the world's leader and center of life
sciences investment. This will be a sustainable strategy to strengthen
Thai economy and improve the quality of life for Thai people.
http://www.tcels.or.th/en/index.asp

TherapyEdge, Inc.
Advanced Biological Laboratories, S.A.
Chalom Sayada, MD, PhD
President and Chief Executive Officer
Tel : +1 919 386 8041 or +352 2638 8921
or
Thailand Center of Excellence for Life Sciences (TCELS)
Telephone +66-2644-5499
Fax +66-2644-9538
Email info@tcels.or.th

Copyright Business Wire 2008